Breaking Finance News

Merck (ETR:MRK) target price raised to 101.00EUR, issued a report today by Joh. Berenberg Gossler & Co. KG

Yesterday Merck (ETR:MRK) traded 0.92% higher at 93.19EUR. The company’s 50-day moving average is 61.63EUR and its 200-day moving average is 60.02EUR. The last stock close price is up 3.65% from the 200-day moving average, compared to the S&P 500 which has decreased -0.03% over the same time. 3,501,268 shares of the stock were exchanged, down from an average trading volume of 10,413,400

Merck (ETR:MRK) had its target price raised to 101.00EUR by Joh. Berenberg Gossler & Co. KG in a report released 11/23/2016. The new target price indicates a possible upside of 0.08% based on the company's last stock close price.

Previously on 11/22/2016, Joh. Berenberg Gossler & Co. KG reported about Merck (ETR:MRK) raised the target price from 0.00EUR to 101.00EUR. At the time, this indicated a possible upside of 0.08%.

See Chart Below

Merck (ETR:MRK)

Merck has a one year low of 47.97EUR and a 52 week high of 65.46EUR with a price-earnings ratio of 31.77 MRK’s total market value is presently 0 EUR.

A total of 20 analysts have released a report on Merck. Two analysts rating the company a strong buy, seven analysts rating the company a buy, thirteen analysts rating the company a hold, zero analysts rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of 61.60EUR.

More About Merck (ETR:MRK)

Merck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company diversifies its activities into four business divisions: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnological origin. The Consumer Health division comprises the over-the-counter products for preventive health care and self-treatment of minor ailments. The Merck Serono and Consumer Health divisions form together the Company's Pharmaceutical business sector. The Merck Millipore division comprises the activities of the Millipore Corporation. The Performance Materials division consists mainly of the Liquid Crystals and Pigments & Cosmetics business units. The Company operates through numerous subsidiaries, including Peer+ BV, AZ Electronic Materials (AZ) and Ormet Circuits Inc., a material supplier for the semiconductor industry.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *